• Elobixibat Hydrate: From IBAT Biology to Translation

  2026-08-09

  Elobixibat hydrate offers translational researchers a gut-focused way to interrogate bile acid circulation, intestinal motility, and metabolic signaling. This article connects selective IBAT inhibition with practical study design, clinical relevance, and a receptor-mapping framework informed by rapakinin research—while clearly separating established evidence from forward-looking hypotheses.

• Fluorouracil: Workflows for Tumor Resistance

  2026-08-08

  Build reproducible 5-Fluorouracil assays around thymidylate synthase inhibition, DNA-replication stress, and resistance biology. This practical guide connects dose–response design with the SMYD2–microRNA–P-glycoprotein findings reported in renal cancer research.

• Gramine Workflow for Ferroptosis Research

  2026-08-07

  Gramine is a mechanism-forward tool for connecting TNBC growth inhibition with ferroptosis, MTDH regulation, and CUL3 activity. This practical workflow covers formulation, dose-response design, target-engagement assays, rescue experiments, and troubleshooting for reproducible cancer biology research.

• Deferoxamine Mesylate: Iron-Chelating Agent for Oxidative St

  2026-08-07

  Deferoxamine mesylate stands out as a precision iron-chelating agent, enabling advanced control of oxidative stress, ferroptosis, and hypoxia signaling in cutting-edge laboratory models. This article delivers actionable workflows, troubleshooting insights, and evidence-driven strategies to maximize the impact of Deferoxamine mesylate in oncology, tissue regeneration, and metabolic research.

• Chemoproteomic SLC15A4 Inhibitors: Mechanisms and Anti-Infla

  2026-08-06

  This study introduces first-in-class, selective inhibitors of the endolysosomal transporter SLC15A4, establishing its role as a druggable target for autoimmune and autoinflammatory diseases. The chemoproteomic approach reveals how these inhibitors modulate critical immune signaling pathways, providing a foundation for targeted therapies with reduced off-target immune suppression.

• DAPI Solution (1 mg/mL): Precision Nuclear Visualization & A

  2026-08-06

  DAPI Solution (1 mg/mL) from APExBIO empowers high-fidelity nuclear visualization and apoptosis detection in both fixed and apoptotic cells, setting a benchmark for workflow optimization in cancer and immunology research. Unique protocol flexibility, robust compatibility with flow cytometry, and proven stability make it a trusted tool for advanced DNA quantification and viability assessment.

• V5 Epitope Tag Peptide: Optimizing Protein Detection Workflo

  2026-08-05

  The V5 Epitope Tag Peptide (GKPIPNPLLGLDST) delivers unmatched sensitivity and reproducibility for protein tagging, detection, and purification in molecular biology. Leveraging high-purity, robust solubility, and compatibility with advanced immunodetection strategies, this tag enables researchers to streamline workflows, troubleshoot challenging assays, and push the boundaries of multiplexed protein analysis.

• UHRF1-Driven DNA Methylation Alters Osteogenesis via TGM2-Au

  2026-08-05

  This study uncovers how UHRF1-mediated DNA 5-methylcytosine modification reshapes super-enhancer architecture and impairs osteogenic differentiation in senile osteoporosis. By connecting epigenetic DNA methylation dynamics to autophagic regulation via TGM2, the findings highlight new mechanistic targets for bone loss intervention.

• Estradiol-GPR30 Signaling Restores T Cell Function After Hem

  2026-08-04

  This study demonstrates that 17β-estradiol restores splenic CD4+ T lymphocyte function after hemorrhagic shock by inhibiting endoplasmic reticulum stress, acting through ERα and GPR30 but not ERβ. The findings clarify receptor-specific mechanisms in post-trauma immune modulation and highlight the utility of selective G protein-coupled estrogen receptor antagonists in dissecting estrogen signaling.

• Superoxide Dismutase (SOD) Activity Assay Kit: Protocol & QC

  2026-08-04

  The Superoxide Dismutase (SOD) Activity Assay Kit enables precise, quantitative measurement of SOD enzyme activity in biological fluids, facilitating research on oxidative stress and antioxidative defense. It is well-suited for workflows requiring rapid, colorimetric detection of SOD activity, but should not be used for diagnostic or clinical applications.

• Y-27632 ROCK Inhibitor: Optimizing Organoid and Cytoskeletal

  2026-08-03

  Y-27632 is a benchmark tool for selective ROCK inhibition, enabling robust cytoskeletal modulation, stem cell survival, and organoid propagation. This guide translates the latest cancer organoid research and advanced cytoskeletal workflows into practical, data-driven strategies for researchers leveraging APExBIO’s trusted Y-27632.

• Alda 1: ALDH2 Activator Workflows for Cardiac and Radiation

  2026-08-03

  Alda 1 unlocks precise modulation of ALDH2 activity, driving advances in both cardiac ischemia and radiation-induced dermatitis models. This article delivers stepwise protocols, evidence-backed troubleshooting, and integration of new cardioprotective insights to help researchers maximize experiment yield.

• Protease Inhibitor Cocktail EDTA-Free: Safeguarding Pluripot

  2026-08-02

  Explore the pivotal role of Protease Inhibitor Cocktail EDTA-Free in protecting protein integrity during embryonic stem cell research. This article uniquely bridges advanced inhibitor technology with the latest breakthroughs in pluripotency and epigenetic regulation.

• L-Alanyl-L-Glutamine: Applied Workflows for Intestinal Barri

  2026-08-01

  L-Alanyl-L-Glutamine unlocks new possibilities in gastrointestinal research, elevating barrier protection and mucosal integrity under even the most challenging catabolic conditions. This article delivers actionable protocol guidance, troubleshooting tactics, and evidence-driven workflow enhancements to help researchers maximize the compound’s translational impact.

• Bacitracin (B1670): Technical Use and Protocol Parameters

  2026-07-31

  Bacitracin (B1670) is a peptide antibiotic designed for laboratory-based antibacterial research, specifically targeting bacterial cell wall and peptidoglycan synthesis. It should be used only in controlled research workflows and is not intended for diagnostic or medical applications.

444 records 8/30 page Previous Next First page 上5页 678910 下5页 Last page